Most medical device, pharma mergers procompetitive, US FTC official says
Most deals involving medical device creators or medicine suppliers are benign transactions that federal officials have no desire to block, but transactions with horizontal or vertical overlaps require vetting, a Federal...To view the full article, register now.
Already a subscriber? Click here to view full article